GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a deal that could be worth up to £268 million ($358 million). The object of ...
We developed and evaluated a pipeline combining Mistral Large LLM and a postprocessing phase. The pipeline's performance was assessed both at document and patient levels. For evaluation, two data sets ...
The last time I spoke about Ironwood Pharmaceuticals (IRWD), it was with respect to a Seeking Alpha article entitled "Ironwood Pharmaceuticals: Q3 of 2024 Data Readout For PBC." With respect to this ...
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close. Software as a service has been a growth driver in the tech industry. Learn about SaaS ...
XPeng’s leadership in autonomous driving technology will differentiate the company and help it defend its market share in the mass market segment amid intensifying competition. Rising competition ...
Macworld reports Apple’s 2026 entry-level iPad is expected to feature the A19 chip, delivering 50% better performance and 8GB RAM compared to the current A16 model. This upgrade enables Apple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results